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ABSTRACT
Wearable biosensors can be used to monitor opioid use, a problem of dire
societal consequence given the current opioid epidemic in the US. Such surveillance can prompt interventions that promote behavioral change. Prior work has
focused on the use of wearable biosensor data to detect opioid use. In this work, we
present a method that uses machine learning to identify opioid withdrawal using
data collected with a wearable biosensor. Our method involves developing a set
of machine-learning classifiers, and then evaluating those classifiers using unseen
test data. An analysis of the best performing model produced a receiver operating characteristic (ROC) area under the curve (AUC) of 0.9997 using completely
unseen test data. Further, the model is able to detect withdrawal with just one
minute of biosensor data. These results show the viability of using machine learning for opioid withdrawal detection. To our knowledge, the proposed method for
identifying opioid withdrawal in OUD patients is the first of its kind.
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CHAPTER 1
Introduction
1.1

Introduction and Motivations
The Center For Disease Control (CDC) has reported that of the 70,000 peo-

ple who died from a drug overdose in the United States during 2017, 68% of those
deaths involved opioids [1]. The treatment process for individuals with opioid use
disorder (OUD) involves detoxification (aka detox), often with medication assisted
treatment (MAT) using drugs such as methadone or buprenorphine [2]. During
the detoxification period, OUD subjects can experience opioid withdrawal symptoms for up to 7 days after their last drug use. Symptoms of opioid withdrawal
include nausea, vomiting, diarrhea, and severe diffuse body pain [3]. These symptoms are often so severe that they have been found to increase the risk of relapse
and overdose death [3]. Some studies have even shown that up to 70% of OUD
subjects relapse after completing opioid detoxification due to the withdrawal they
experience. [4]. The process of opioid detoxification is complicated and difficult
for both healthcare practitioners and subjects.
Up until the past few decades, the evaluation of patient health and wellbeing
was limited to when a patient visited their healthcare provider [5]. More recently,
the improvements in commercially available wearable biosensors have given healthcare providers the capability to monitor various aspects of the physiological state
of their patients health remotely [5]. These analytical devices can be worn at all
times by patients, and can collect and transmit key indicators of patient physiology
in real time. Wearable biosensors have already been shown to have potential for
detecting and managing opioid use in real-time [6] [7] [8]. Undergoing the detoxification process, and experiencing opioid withdrawal can be difficult for OUD
patients. Improving the clinician’s ability to monitor subjects during withdrawal
1

(e.g. while in a detoxification program) would help clinicians personalize treatment
options for relapse prevention. Personalized treatment for opioid withdrawal has
the potential to improve treatment success and ultimately save lives.
In this work, we present a method that uses machine learning to identify opioid
withdrawal using data collected with a wearable biosensor. To develop and evaluate
our approach for detecting opioid withdrawal using biosensors, we rely on using
biosensor data collected from overdosing subjects in a hospital emergency department (ED). We used an Empatica E4 wrist-mounted biosensor (Empatica, Milan,
Italy) for our data collection. Data was collected from 16 subjects who presented
to a single ED for medical care following an opioid overdose. The subjects were in
various states of recovery subsequent to an administration of naloxone 1 . Our subjects were real medical patients suffering from OUD, and all data was gathered in
a way that prioritized subject care and wellness over research goals with approval
from our Institutional Review Board (IRB).
In order to detect withdrawal, we use standard machine learning techniques to
develop classifiers that capture the uniqueness of the physiological measurements
collected by the Empatica E4 during withdrawal. The physiological measurements
collected are blood volume pulse, electrodermal activity, skin temperature, and
movement (accelerometry). During their stay in the ED, the subjects were evaluated by clinicians every 30 minutes to an hour. At each of these evaluations the
subjects were assessed to be in one of three states – withdrawal, intoxicated, or
neutral. We decided to use a 20 minute interval surrounding the time when the
physician assessed the physiological state of a subject for training and testing our
models, as we had confidence in the ground-truth of a subject’s state during that
time. The classifiers developed were general models essentially able to distinguish
1

Naloxone is an antidote that is given to someone who is overdosing on opioids. It immediately
reverses the effect of opioids by competitively binding to the opioid receptors in the body

2

the withdrawal state from all other states.
In total, our dataset had data collected from 16 different OUD subjects. Six
of the 16 subjects had data in the withdrawal state. Two of these six subjects
had neutral data as well, the other four had data exclusively in the withdrawal
state (based on the clinician’s assessment). The remaining 10 other OUD subjects
used in this study had data assessed in either the neutral or the intoxicated states
or both. This means our dataset has many more examples in the neutral and
intoxicated states compared to the withdrawal state. This class imbalance had to
be addressed during the development of our models.
The analysis presented in this work demonstrates the viability of our method.
Upon training our models, and compensating for the class imbalance, we were able
to achieve almost perfect results using our test data. The best performing model
(Random Forest) during testing had a receiver operating characteristic (ROC) area
under the curve (AUC) of 0.9997. Our test data was completely unseen data (by
our models during training) including both withdrawal and non-withdrawal states.
Further, the model is able to detect withdrawal with just one minute of biosensor
data. To the best of our knowledge, this is the first work related to using machine
learning to identify opioid withdrawal of any kind.
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CHAPTER 2
Literature Review
2.1

Related Work
As previously mentioned, we do not know of any work that has been done

related to using wearable biosensors to detect opioid withdrawal. The majority of
research involving identifying opioid withdrawal is related to the development of
clinical tools whose purpose is to assess a patient for withdrawal symptoms. The
common form these clinical tools come in are surveys or scales [1]. One commonly
used assessment tool is the the Clinical Opiate Withdrawal Scale (COWS). This
scale considers a number of different physiological symptoms to help medical staff
identify to what extent a patient is experiencing opioid withdrawal [2]. These
opioid withdrawal scales have limitations since signs and symptoms may go unrecorded when clinicians are not observing a patient, and they require patients to
self report certain symptoms [1]. There has also been previous pharmacological
research that conceptualizes opioid withdrawal as a stressor [3].
There are many studies that have used machine learning to identify stress.
Data collected from wearable biosensors has been used to successfully build both
personalized and general models for detecting stress. [4] [5].
Limited work has been done related to stress detection in Substance Use Disorder (SUD) patients [6], but no such work has been done related to OUD patients.
However, since it has been shown that opioid withdrawal symptoms can be conceptualized as being similar to those of stress [3], we will leverage some of the features
of stress detection in this work. Specifically, there are two works related to using
wearable biosensors to detect stress which heavily influenced the methodology for
this research. The synopsis for these two studies are detailed below.
The first work titled “Real-Time Monitoring of Passenger’s Psychological
5

Stress” by Vila et. al. [4] seeked to develop a personalized stress detection model
using data collected from a wearable biosensor. In this study, the Empatica E4 was
worn by the chosen subject during business travel to collect training data. During
the collection of data, the subject was asked to rate their stress during different
activities on a scale from 1 to 10. The training data was then labeled with the
self-reported stress levels. The sensor during this time collected data for blood
volume pulse (BVP), electrodermal activity (EDA), and 3 axis acceleration. This
training dataset was then broken into non-overlapping 60 second windows, where
each window had 24 different features extracted from it. The 24 training features
extracted from a particular 60 second window represented one training instance.
The training data was then used to develop a linear regression model to predict
a label of stressed, or not-stressed. This personalized linear regression model for
detecting stress was deployed on a mobile application to test the ability of the
model to label stress in real-time. The participant then went on travel for business
again to collect test data, only this time the Empatica E4 was paired with the already trained personalized stress detection model on the participants phone. This
trained personalized stress detection model labeled the data collected in real-time,
and at the same time the participant also labeled their data manually (as stress
or not-stressed). The real-time prediction of the algorithm was compared with the
participants labeling of their stress levels during this test phase. The model was
successful at distinguishing between stress and non-stress, and correctly labeled
large chunks of time reported as least stressful (1/10 stress level) 96.5 % ± 3.2. It
was stated in this paper that the features extracted for the model were not supposed to be the optimal feature set for detecting stress, but a baseline of features
which can be used to detect stress in real-time. [4]
In the second work, ”Continuous Stress Detection Using Wearable Sensors in
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Real Life: A Programming Contest Case Study” [5], 21 students were enrolled
during a programming camp to build a general model for classifying stress. Each
participant was assigned to wear a smart watch to collect their biometric data (2
Samsung Gear S1, 10 Samsung Gear S2, 4 Samsung Gear S3 smartwatches and
4 Empatica E4 wristbands). Three different activities were performed during the
camp: free time, lecture, and competition. Each activity was given a pre-defined
stress level by the researchers (free time: low, lecture: medium, competition: high).
They obtained a subjective stress level by asking participants during their activities
what their stress level was on a 0-100 scale with increments of 5 (0-30 is low, 35-75
is medium, 80-100 is high). They collected data for blood volume pulse (BVP),
electrodermal activity (EDA), and 3 axis acceleration. This data was used to train
and test 6 different models (PCA + LDA, PCA + SVM (radial), kNN, Logistic
Regression, Random Forest, Multi-layered perceptron). The models built using
the pre-defined stress level, and the subjective stress level were both successful at
identifying stress. The top performing models were the Random Forest and Multilayered perceptron. The best general model for identifying stress had an accuracy
of 88.20%, while the best person-specific model had an accuracy of 97.92%.
Wearable biosensors have also been used in opioid research for automatic
detection of opioid intake [7] [8], and detecting recurrent opioid toxicity in patients
after being administered naloxone [9]. The non-adherence of opioid abuse disorder
patients wearing a biosensor has also been recently investigated [10]. None of these
previous studies looked to use wearable biosensors to identify opioid withdrawal.
Therefore, there is a need to explore using wearable biosensors to detect opioid
withdrawal.

7

Figure 1: Overview of problem statement for developing a classifier to detect opioid
withdrawal.
2.2

Problem Statement
The goal of this paper is to explore the use of machine learning for identify-

ing opioid withdrawal. The idea is to build a model that learns to differentiate
physiological data (collected from wearable biosensors) assessed to be in the withdrawal state, from data assessed in either the neutral or intoxicated state (i.e.,
non-withdrawal state). Once developed, this model will be able to assess whether
or not a never before seen snippet of data has come from an OUD patient in the
withdrawal state. As shown in Figure 1, we aim to build a binary classifier that
can distinguish between biosensor data emanating from a person in withdrawal
versus a person not in withdrawal.
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CHAPTER 3
Methodology
In this chapter we first describe the collection, and cleaning of our dataset.
Next, we will describe the feature extraction process, and an overview of the training and testing procedures.
3.1

Data Collection
The dataset used in this study was collected from individuals (patients) admit-

ted to the emergency department (ED) who received naloxone after experiencing a
potential opioid overdose. Upon obtaining informed consent, research staff placed
an Empatica E4 wearable biosensor on the patients non-dominant wrist in order
to collect their biometric data. The E4 collects four different types of data from
the body.
One of the standard tools used by clinicians to assess whether a patient has
opioid withdrawal symptoms is the Clinical Opiate Withdrawal Scale (COWS) [1].
The COWS considers, among other biometrics, a subjects heart rate, perspiration,
and acute movements. Given that the Empatica E4 collects some of the exact data
types used in the COWS, we used these same biometrics in our analysis. Specifically, in our work we used blood volume pulse (BVP) (sampled at 64 Hz) data,
electrodermal activity (EDA) (sampled at 4 Hz) data, skin temperature (sampled
at 4 Hz) data, and triaxial accelerometer (sampled at 32 Hz) data. While the
COWS doesn’t consider a patient’s skin temperature in its assessment for opioid
withdrawal symptoms, there are several other opiate withdrawal scales that do [2].
Along with the data collected by the E4, the physiological state of a patient
was assessed and recorded by a board-certified emergency physician and medical
toxicologist in the ED. The physiological state of a patient was classified as one
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Table 1: Demographics of our dataset
Gender
Male
Female

Count
13
3

Avg. Age (std)
34.85 ± 9.89
38.33 ± 2.05

of three states based on clinician assessment: neutral, intoxicated, or withdrawal.
The neutral state refers to a patient not being in opioid intoxication or opioid withdrawal. The intoxicated state refers to a state with signs and symptoms consistent
with opioid intoxication. The withdrawal state refers to a state with signs and
symptoms of opioid withdrawal. The assessment of a subjects physiological state
took place every 30 minutes to an hour. Subjects assessed in the intoxicated or
withdrawal states were generally laying on a hospital stretcher due to incapacity or
discomfort, respectively. The neutral state assessments were often done while the
participant was performing a variety of activities such as walking, talking, eating,
etc. A patient may have been assessed in variety of different states during their
enrollment in the study. It was not uncommon for subjects to transition from one
state to another during the course of the study: for example to be neutral on one
assessment, then to be in a withdrawal state on a second assessment 30 minutes
later. The clinicians assessment of the state of the patient provides us with the
ground-truth needed to build our models. Overall, we used data from 16 subjects
in this study. The demographics of the patient population can be found in Table
1.
3.2

Data Cleaning
All of the data used in this study was visualized graphically to verify the

quality of the data. All datatypes collected by the Empatica E4 that were used in
this study are described in detail in Section 3.1. Visualizing the data graphically
revealed areas of problematic data in both the electrodermal activity (EDA) and
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Figure 2: Example of data collection process.
blood volume pulse (BVP) data for some of the patients. These problematic areas
or artifacts can be characterized by spikes in the data which are due to noise.
Artifacts can appear in both BVP and EDA data due to movement of the biosensor
on the skins surface [3] [4]. In order to mitigate the effect of the artifacts present
in the BVP and EDA data, a data cleaning process was undertaken for these two
data types. The process for cleaning the EDA, and BVP data is detailed in the
next few paragraphs.
Specifically, we used filtering techniques to clean the EDA and BVP data. In
order to mitigate noise in the EDA data, two low-pass Butterworth filters were
applied to the data. The first low-pass Butterworth filter had a cutoff of 0.2 Hz,
and the second low-pass Butterworth filter had a cutoff of 0.05 Hz. The use of
this technique for the purpose of noise reduction in EDA data has been shown
to be successful in previous research [5]. The purpose of applying these two lowpass Butterworth filters is to first use the 0.2 Hz low-pass filter to rid the data
of drastic peaks caused by noise, and then apply the 0.05 Hz filter to smooth out
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the remaining signal. [5]. Figure 3 shows an example of how the two-low pass
Butterworth filters applied to EDA data helps mitigate motion artifacts.

Figure 3: Example of two low-pass Butterworth filters being used to clean a patients EDA data.
The visual inspection of each patients BVP data revealed that noise was spread
throughout the signal in every patients data. Noise artifacts in BVP data is a well
documented problem, and many different studies have proposed solutions for it [3].
A band-pass filter was the chosen technique to limit the impact of noise present
in the BVP data. This band-pass filter had a high-pass cutoff of 0.6 Hz, and a
low-pass cut off of 3.33 Hz. These lower and upper frequencies are used to limit
the possible heart rates that could appear in this data to a range of 40-200 beats
per minute (BPM). This heart rate range accounts for both the upper and low
extremes of heart rates that could occur for an individual [6]. Figure 4 shows an
example of how the band-pass filter applied to BVP data helped mitigate motion
artifacts.
The accelerometer data did not undergo any data cleaning in order to maintain
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Figure 4: Example of band-pass filter being used to clean a patients BVP data.
acute movements that may be related to opioid withdrawal symptoms. No data
cleaning was performed on the skin temperature data, however an inspection of
the skin temperature data revealed that some skin temperature readings were far
lower than the patients normal skin temperature reading. The sections of data
containing abnormally low skin temperature readings were not included in our
analysis.
3.3

Dataset Windowing
After cleaning each patients data, it then needs to be discretized. In order to

discretize the time series data collected with the Empatica E4 wearable biosensor,
a sliding window technique was used. The sliding window technique is a data
processing method used to break up continuous data into time windows of a fixed
size [7]. The size chosen for a fixed time window is based off of how much time is
needed to make a judgement about a particular signal. These fixed sized windows
can be non-overlapping, or overlap each-other in order to obtain finer details about
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how a signal is changing over time. A non-overlapping window size of one minute
was chosen to break up each patients data. A one minute non-overlapping window
size was used because this window-size has been used in previous research related
to classifying stress using machine learning [5]. As previously mentioned, opioid
withdrawal can be conceptualized as being similar to stress [8].

Figure 5: Example of data curation process applied to withdrawal state data.
The one minute segments that were assessed to be in the withdrawal state
are placed into one dataset (the universal withdrawal set), and the one minute
segments that were assessed to be in the intoxicated or neutral state were placed
into a separate dataset (the universal non-withdrawal set) (see Figure 5). Once
all patient data was placed into either the universal withdrawal or universal nonwithdrawal dataset, the feature extraction process was performed.
3.3.1

Detailed Breakdown of Data Windows

Prior to discussing the feature extraction process, we first provide a detailed
breakdown of the one minute data windows used in this analysis. The break down
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of how many one minute data windows a subject had in each state, as well as
the grand totals is shown in Table 2. Each data window here equates to one class
points after the feature extraction process is performed. It is clear that there are far
fewer withdrawal state windows compared to the combined total of neutral state
and intoxicated state windows. We also show here that many subjects had data in
more than one state, and that two of our subjects with withdrawal state data also
had data in the neutral state. As previously mentioned in the Section 3.2 (Data
Cleaning), certain patients had noisy or abnormal data which was excluded from
our analysis. This is why some patients have far fewer one minute data windows
compared to others (e.g. Subject N0025 had only 9 minutes of usable neutral state
data).
Table 2: Number of data windows extracted from each state for a subject
Subject
N0002
N0004
N0008
N0013
N0015
N0017
N0022
N0023
N0024
N0025
N0026
N0027
N0029
N0032
N0033
N0045
Grand Total

Total Windows
18
11
17
47
19
64
28
30
25
9
35
17
34
19
19
27
419

Neutral
18
0
0
19
19
7
0
19
25
9
0
17
19
0
0
0
152
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Intoxicated
0
11
17
0
0
57
28
11
0
0
0
0
0
0
0
0
124

Withdrawal
0
0
0
28
0
0
0
0
0
0
35
0
15
19
19
27
143

3.4

Feature Extraction
Once all of the data has been broken up into one minute segments and placed

into either the universal withdrawal or universal non-withdrawal datasets, we can
then generate feature vectors from each one minute of data. The features extracted
for this analysis are inspired by two of the works detailed in Section 2.1 (Related
Work) which used wearable biosensors to classify stress [5] [9].
There are a total of 66 features extracted from each one minute window during
feature extraction. These 66 features form a feature-vector that is then labeled as
belonging to a positive or negative class. The positive class feature-vectors are
derived from data collected in the withdrawal state and negative class featurevectors are derived from data collected in the intoxicated or neutral states. The
positive and negative class points are detailed further in Section 3.5.
The features extracted from the EDA, BVP, skin temperature, and triaxial
accelerometer data are described in Table 3.
In total, there are 11 features extracted from the EDA data, 14 features extracted from the BVP data, 13 different features extracted from each axes (x, y,
z) of the triaxial accelerometer data (39 in total), and 2 features extracted from
the skin temperature data.
Separability of Features
Prior to detailing how we used these features to train our models, we will
provide an intuition for why these features may help a model to distinguish between
the withdrawal and non-withdrawal states. We do this by plotting a pair of features
for each class point in our analysis: one feature on the x-axis, and one feature on
the y-axis.
In Figure 6, we show a pair of features that highlight the separability of
the positive and negative class points. Here, we show the mean inter-beat interval
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Table 3: Features extracted from each datatype collected by the Empatica E4
Datatype

EDA

BVP

Triaxial Accelerometer (x, y, z)

Skin Temperature
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Features Extracted
mean, mean derivative,
standard deviation, number of peaks, mean prominence, mean width between peaks, dot product of the peak width
and prominence, number
of strong peaks, 20th percentile, quartile, 80th percentile
mean inter-beat interval
(IBI), IBI standard deviation, root mean square, total power of IBI, low frequency power of IBI, high
frequency power of IBI,
normalized low frequency
power of IBI, normalized
high frequency power of
IBI, low frequency power
to high frequency power
ratio of IBI, number of
peaks, mean amplitude,
standard deviation of amplitude, square average,
percent of IBI greater than
50 milliseconds.
total power, mean absolute difference of the
norm, mean derivative,
mean, median, skew, variance, standard deviation,
maximum,
minimum,
interquartile range, zero
crossing rate, kurtosis
mean, mean derivative

feature plotted against the mean EDA feature for each class point. The mean EDA
is a measurement of the average conductivity level of the skin [10]. The higher the
conductivity level of the skin or EDA, the more a person is sweating [10]. The
mean inter-beat interval is the average amount of time, in milliseconds, between
heart beats [11]. Although there is quite a bit of overlap between withdrawal class
and non-withdrawal class samples at low values of the mean EDA (between 0 and
0.25 microsiemens), the majority of non-withdrawal points have a lower EDA, and
higher inter-beat interval. This is what one would expect to see. When a person
is not in withdrawal they are less sweaty and their heart is not beating very fast.
The opposite is however true, generally speaking, when one is in withdrawal.
Specifically, about 40% of non-withdrawal class points have an EDA below
0.15 microsiemens, compared to only 13% of withdrawal class points. At the same
time, over 70% of withdrawal class points have an inter-beat interval below 35
milliseconds, compared to only 50% of the non-withdrawal points. A low interbeat interval (or faster heart rate), and a higher average EDA (sweatiness) are
exactly what scales like the COWS expect to find in a patient experiencing opioid
withdrawal [1].
3.5

Training And Testing Overview
Once we have the dataset and know which features to extract, the next step

is to build the opioid withdrawal detection model. Our detection model uses a
machine learning-based classifier to address our principal question.
Our classifier attempts to learn the uniqueness of the EDA, accelerometer,
temperature, and BVP data (collected using the wearable biosensor) for the OUD
subjects withdrawal state. Once the model is built, any newly received EDA,
accelerometer, temperature, and BVP data snippet which matches the models
understanding of the withdrawal state will be classified as such. Our detection
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Figure 6: Comparison of the mean inter-beat interval and EDA mean values for
each class point.
approach has two phases: the training phase, and the testing phase.
3.5.1

Training Phase

The goal of the training phase is to develop a machine-learning model (specifically, a binary classifier) for identifying opioid withdrawal, where our model needs
to be able to recognize the withdrawal state from a variety of non-withdrawal
states. In order to do this, we must first label the subjects data into one of two
different classes. (1) Positive Class: The positive class consists of all 66-point
feature vectors from the six different subjects whose data were assessed to be in
the withdrawal state. (2) Negative Class:

The negative class consists of all

66-point feature vectors from the 12 different subjects whose data were assessed to
be in the non-withdrawal state. In our study, the non-withdrawal class refers to
subject data assessed in the neutral and intoxicated states. These two physiological states are lumped together into the non-withdrawal state because the primary
goal of our analysis is to evaluate how well a machine-learning classifier can dis-
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Figure 7: Overview of the training and testing methodology.
tinguish the withdrawal state from other physiological states found in our subjects
population.
3.5.2

Testing Phase

Once the machine learning model is trained, it is now able to classify whether
a 66-point feature vector, derived from a never before seen one minute snippet of
EDA, accelerometer, temperature, and BVP measurements, belongs to the withdrawal or non-withdrawal state. Since we are performing binary classification
(withdrawal vs. non-withdrawal), our classifier typically returns a confidence value
from 0 to 1, with 1 indicating that the model has full confidence that the unseen
snippet belongs withdrawal state, and with 0 indicating full confidence that the
point belongs to the non-withdrawal state. We are then able to decide whether to
accept or reject that value depending on whether or not it meets a chosen threshold
between 0 and 1. A diagram of our withdrawal detection approach is shown in
Figure 7. Since we are using a one minute window, our model requires one minute
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of data to be collected by a wearable biosensor before it can classify whether that
person is in the withdrawal or non-withdrawal state.
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CHAPTER 4
Model Development
In this chapter, we discuss the curation of our data set, how we will evaluate
the machine learning models we develop, and the results of our model training
process.
4.1

Data Curation
In this section, we will describe the data curation process. The data curation

process involves extracting portions of the patient data, and creating two separate
datasets for training and testing.
Given that the subjects in our dataset were examined by clinicians intermittently (every 30 minutes to an hour), we do not have the ground-truth about the
patients health state at all times. Consequently, we curate the biosensor data
collected from the 16 patients by only extracting patient data where we are reasonably confident of their health state (i.e., neutral, intoxicated or withdrawal).
Only this curated data is used for training our detection models and evaluating
their efficacy.
In total, we used data from 16 different patients in this study. Each patient
had their physiological data collected anywhere from 30 minutes up to several
hours. Of these 16 different patients, only 6 had withdrawal symptoms assessed by
clinicians. One of the 6 patients that had data in the withdrawal state, one also
had usable data assessed in the neutral state. The remaining 10 patients had data
assessed in the neutral state, intoxicated state, or both.
A total of 20 minutes were extracted from the wearable biosensor data surrounding the time when the clinicians assessed the patient’s state. The 20 minutes of data is comprised of the 10 minutes before and the 10 minutes after the
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evaluation happened. We used these 20 minutes of data because, being in the
controlled environment of the hospital, it is unlikely a patients physiological state
would change drastically during this time period. However, certain parts of the 20minute periods surrounding an assessment of a patient’s state had to be excluded
from our analysis due to noise issues described in Section 3.2.
The one minute segments that were assessed to be in the withdrawal state
are placed into one dataset (the universal withdrawal set), and the one minute
segments that were assessed to be in the intoxicated or neutral state were placed
into a separate dataset (the universal non-withdrawal set) (see Figure 5). Once
all patient data was placed into either the universal withdrawal or universal nonwithdrawal dataset, the feature extraction process was performed.
To be able to train the classifier to detect withdrawal, we have to compensate
for the idiosyncrasies in our curated dataset that originated from our data collection
protocol. In order to train our classifier, we first generate the positive and negative
class points (as described in Section 3.4) and then shuffle them. We then use the
first 80% of the feature points for training. This allowed us to train our classifier
and still have some (previously unseen by the model during training) data leftover
(20%) to test its performance.
Table 4 shows the break down class points in the training and testing sets.
This highlights the small sizes of both the training and test set, as well as the
imbalance between the withdrawal and non-withdrawal class points.
Table 4: Breakdown of class points in training and testing sets
Training Set
Testing Set

Total Points
335
84

Withdrawal Points
113
30
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Non-Withdrawal Points
222
54

4.2

Metrics
Before we go into the details of the how the different machine learning models

will be trained and tested, we provide a short overview of the metrics we use
to evaluate the efficacy of our models. Since our model will classify each input
example as either withdrawal (positive class) or non-withdrawal (negative class),
the result from inference will fall into one of four categories. (1) True Positive (TP):
A correct prediction of the positive class. (2) False Negative (FN): An incorrect
prediction of the positive class. (3) True Negative (TN): A correct prediction of
the negative class. (4) False Positive (FP): An incorrect prediction of the negative
class. After performing inference on all input examples, we will use the number of
examples in each of these four categories to calculate our models true positive rate
(TPR), and false positive rate (FPR).
TPR is the ratio of how many positive class points were predicted correctly
compared to the total number of positive class points [1]. FPR, on the other hand,
is the ratio of how many negative class points were predicted incorrectly compared
to the total number of negative class points [1]. The TPR and FPR for a model can
be used to plot a receiver operating curve (ROC). The ROC curve demonstrates
how well a model classifies positive points, compared to how poor it is at classifying
negative points [1]. From the ROC curve, the area under the curve (AUC) can be
calculated to allow us to compare one machine learning model to another. The
ROC AUC is the metric that we use to measure how accurately our models can
identify the withdrawal class samples. The ideal ROC curve should have an AUC
value that is close to 1 (perfect classification of both positive and negative class
points). The ROC AUC will be the metric we will attempt to maximize during
the training and testing processes.
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4.3

Model Training
Once the dataset had been cleaned, the features extracted, and the training

and test sets created, we can begin developing models to identify opioid withdrawal. We trained four different machine-learning classifiers to identifying opioid
withdrawal. The classifiers use all 66 features extracted from the wearable biosensor data to learn what distinguishes the withdrawal state from the non-withdrawal
(neutral or intoxicated) state. The four machine-learning (ML) algorithms developed in this training phase are: Random Forest, Decision Tree, Logistic Regression,
Support Vector Machine (using a gaussian radial basis function kernel).
To first develop a baseline understanding for how our models perform during
training, we performed 10-fold cross validation with our class imbalanced training
dataset using all 66 features and untuned models. The ROC Curves and AUC for
each algorithm for this baseline test are shown in Figure 8. What is shown in this
figure is that all untuned algorithms perform fairly well using class imbalanced
data, and all 66 features. The Random Forest performs especially well (AUC
= 0.9690), and is still fairly close to near perfect classification. The Decision
Tree (AUC = 0.8556), Logistic Regression (AUC = 0.8615), and Support Vector
Machine (AUC = 0.8089) models perform well, but have much more room to
improve compared to the Random Forest.
Now that we have a baseline for how these algorithms perform during cross
validation without addressing the class imbalance, we decided to use two different
class imbalance techniques in an effort to improve classification. These two approaches are Synthetic Minority Oversampling Technique (SMOTE) and Exactly
Balanced Bagging (EBBag). The SMOTE technique samples a point p from the
minority class, and randomly creates a new point that is between p and its r closest neighbors [1]. This is done until the positive class and negative class have an
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Figure 8: Average ROC curves and AUC obtained during cross validation with
class imbalanced data using all features and untuned models.
equal amount of examples. This technique has been found to be very effective for
handling class imbalances [1]. EBBag involves training more than one instance
of a classifier on randomly under-sampled sets of the majority class which match
the number of samples in the minority class [2]. This technique was done without
replacement, and allows us to train two different classifiers which both used all of
the withdrawal state data, and equally split the non-withdrawal state data. These
two classifiers then work together to perform inference on new samples presented
to them.
4.3.1

Feature Pruning

Further, in order to improve our models we pruned the feature set. The
purpose of doing this is to find a minimal feature set which maximizes a models
ability to identify the withdrawal state. The feature pruning process is done by
starting with an empty set of features for a particular model, and at each stage
adding the feature to its feature set which maximizes its ability to accurately
identify withdrawal class samples during cross-validation. If all of the 66 extracted
features are in the models feature set, or there are no features left which improve
the models ability to accurately identify the withdrawal class samples, then the
process ends. A minimal feature set is identified for each model using both of the
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techniques for handling the class imbalance (SMOTE, EBBag).
4.3.2

Grid Search

Next, once we have the optimal feature set for a model, a grid search is
performed to find the hyper-parameters which maximize the model’s ability to
accurately identify withdrawal class samples during cross-validation. Previous research has shown that using a grid search with cross validation to assess different
hyper-parameter values for a model can help find which hyper-parameter values
maximize a models ability to perform inference [3]. The hyper-parameters chosen
to be tuned via a grid search in this study have all been used in previous research
for hyper-parameter optimization [4] [5] [3]. The hyper-parameters optimized for
each model are summarized in Table 5. Combined, the minimal feature set and
model with tuned hyper-parameters will be used in the testing phase.
Table 5: Hyper-parameters chosen to be optimized for each model
Model
Random Forest

Decision Tree
Support Vector Machine
Logistic Regression

Hyper-parameters optimized
maximum depth, minimum samples per leaf, minimum samples
per split, number of estimators
maximum depth, minimum samples per leaf, minimum samples
per split, splitting criterion
cache size, degree
inverse regularization strength

The results of the training phase will help determine which models will be used
in the testing phase for both the SMOTE and EBBag class imbalance techniques.
4.3.3

Training using SMOTE

Initially we use all 66 features to build our models using our four chosen ML
algorithms. We use SMOTE to compensate for the class imbalance. Figure 9 shows
the results when all features are used. We find that Random Forest (RF) performs
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Table 6: Feature pruning results using SMOTE
Model
Random Forest

Decision Tree

Logistic Regression

Support Vector Machine

Pruned Feature Set
mean temperature, EDA
mean, x-axis median, yaxis interquartile range, zaxis interquartile range
mean temperature, EDA
20th percentile,
EDA
mean, z-axis median
mean temperature, EDA
peaks, EDA mean, x-axis
total power, y-axis interquartile range, y-axis
zero crossing rate, y-axis
minimum, y-axis skew
mean temperature, EDA
20th percentile, y-axis median, z-axis mean

the best with a near perfect classification accuracy (AUC = 0.9785). The other
algorithms do not perform as well. Next, we used the feature pruning algorithm
to find the minimal feature set which maximizes classifier accuracy. Table 6 shows
the reduced/pruned features list (again using SMOTE to balance the classes).
Using these pruned feature sets, we find that the performance of the all of the
algorithms except for the Decision Tree algorithms remain more or less the same.
The Decision Tree algorithm saw improvements from an AUC of 0.8625 using all
features, to an AUC of 0.9235 using the pruned feature set (see Figure 10). Finally,
a grid search was performed to determine the optimal hyper-parameters for a model
when using SMOTE. The model parameters which were tuned during this process
using SMOTE can be seen in Table 7. The final results using SMOTE with each
tuned model, and pruned feature set (see Figure 11) show the same performance
as using an untuned model.
.
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Table 7: Grid Search Results Using SMOTE
Model
Random Forest

Decision Tree

Logistic Regression
Support Vector Machine
4.3.4

Hyper-parameter
Criterion
Minimum Samples Per Leaf
Minimum Samples Per Split
Number of Estimators
Max Depth
Criterion
Minimum Samples Per Leaf
Minimum Samples Per Split
Max Depth
Cache Size
Degree
Inverse Regularization Strength

value
gini impurity
1
2
100
15
gini impurity
1
2
10
5
1
11.28

Training using EBBag

Initially we use all 66 features to build our models using our four chosen ML
algorithms. We use EBBag to compensate for the class imbalance. Figure 12
shows the results when all features are used. We find that the Random Forest
(RF) algorithm performs the best (AUC = 0.9666) of all the models when using
all features. Though the Random Forest algorithm performed well using EBBag,
compared to SMOTE, the AUC for all algorithms except for the Decision Tree
(AUC = 0.9074) was worse than when using SMOTE. Next, we used the feature
pruning algorithm to find the minimal feature set which maximizes classifier accuracy. Table 8 shows the reduced/pruned features list (once again using EBBag to
balance the classes). Unlike SMOTE, using these pruned feature sets noticeably
improves the performance of the four algorithms. After using the feature pruning
algorithm, the Random Forest (RF) and Decision Tree (DT) algorithms performed
slightly better than the results obtained using SMOTE (see Figure 13). Finally, a
grid search was performed to determine the optimal hyper-parameters for a model
when using EBBag. The model parameters which were tuned during this process using EBBag can be seen in Table 9. The final results using EBBag with
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each tuned model, and pruned feature set (see Figure 14) show that all models
performed the same or slightly better than the untuned models.
Table 8: Feature Pruning Results Using EBBag
Model

Random Forest

Decision Tree

Logistic Regression

Support Vector Machine

4.3.5

Pruned Feature Set
mean temperature, EDA
mean, BVP Root Mean
Square, x-axis median, yaxis minimum, BVP mean
IBI
mean temperature, EDA
mean, x-axis median, zaxis maximum, EDA 20th
percentile
mean temperature, EDA
mean, EDA peaks, y-axis
median, x-axis mean average derivative, x-axis total power, number of BVP
peaks, z-axis zero-crossing
rate, y-axis variance
mean temperature, EDA
peaks, EDA 20th percentile, y-axis maximum,
z-axis median, BVP root
mean square

Comparison Between Using Imbalanced Data And Using
SMOTE or EBBag

The baseline results obtained with untuned models using imbalanced data and
all 66 features (see Figure 8) can now be compared to the initial results obtained
using SMOTE (see Figure 9) and EBBag (see Figure 12). When comparing the
results for SMOTE with using no class imbalance technique, we can see that the
results are fairly similar for all algorithms. However, when comparing the EBBag
results with using no class imbalance technique, we can see that the Decision Tree
algorithm performs better with EBBag (AUC = 0.9074) compared to using no class
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Table 9: Grid Search Results Using EBBag
Model
Random Forest

Decision Tree

Logistic Regression
Support Vector Machine

Hyper-parameter
Criterion
Minimum Samples Per Leaf
Minimum Samples Per Split
Number of Estimators
Max Depth
Criterion
Minimum Samples Per Leaf
Minimum Samples Per Split
Max Depth
Cache Size
Degree
Inverse Regularization Strength

value
gini impurity
2
5
100
8
entropy
1
3
8
5
1
1.62

imbalance technique (AUC = 0.8556). We can also see that the Support Vector
Machine model using EBBag (AUC = 0.7545) performs worse than the Support
Vector Machine model using no class imbalance technique (AUC = 0.8089). In
general though, our cross validation training results do not demonstrate that using
either class imbalance technique (SMOTE, EBBag) provides a great advantage to
simply using the imbalanced data. Since these initial results do not show that these
class imbalance mitigation techniques (SMOTE, EBBag) improve classification,
we decided to use the untuned models trained with imbalanced data and all 66
features, as well as the models using SMOTE and EBBag in the testing phase. We
will again compare and contrast models trained using the imbalanced data with
those trained using SMOTE and EBBag in the testing phase.
4.3.6

Comparison Between SMOTE and EBBag Pruned Features

During the feature pruning process for the Random Forest (RF) algorithm,
three of the same features were found to maximize classification accuracy during
training using both SMOTE and EBBag. These features are mean temperature,
EDA mean, and x-axis median. This is a high percentage of similar features con-
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sidering that the number of features in the pruned feature set for the RF algorithm
using SMOTE and EBBag are five and six respectively. For all four algorithms,
generally around half of the pruned feature list using SMOTE and EBBag were
the same. The most commonly found features in the pruned feature sets for all
of the algorithms (using either SMOTE or EBBag) are mean temperature, and
EDA mean. EDA mean is one of the features highlighted in Section 3.4, which
helped demonstrate the separability of the positive and negative class by plotting
one feature against another.
4.3.7

Comparison Between SMOTE and EBBag Tuned Models

The tuned models using SMOTE and EBBag were similar for certain algorithms and very different for others. The Decision Tree models developed using
SMOTE and EBBag were relatively similar, where only the minimum samples per
split (tuned value using SMOTE was 3, and for EBBag was 2) and maximum depth
(tuned value using SMOTE was 10, using EBBag was 8) were different for the tuned
models. The tuned Support Vector Machine models using the two class imbalance
techniques were exactly the same. On the other hand, the Logistic Regression
and Random Forest tuned models were very different when using SMOTE versus
EBBag. The inverse regularization strength value for the tuned Logistic Regression models using SMOTE was far higher (tuned value using SMOTE was 11.27,
and for EBBag was 1.62). For the Random Forest models developed using SMOTE
and EBBag the major differences were in the maximum depth (tuned value using
SMOTE was 15, using EBBag was 8), minimum samples per split (tuned value
using SMOTE was 2, and for EBBag was 5), and minimum samples per leaf (tuned
value using SMOTE was 1, and for EBBag was 2).
Ultimately, since our training results do not show a dramatic improvement
between using a tuned vs. untuned model, we decided to use both the set of
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untuned models and tuned models in the testing phase.
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Figure 9: Average ROC curves and AUC obtained during cross validation for
SMOTE using all features.

Figure 10: Average ROC curves and AUC obtained during cross validation for
SMOTE using the pruned features.

Figure 11: Average ROC curves and AUC obtained during cross validation using
SMOTE for each tuned model using the pruned features.
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Figure 12: Average ROC curves and AUC obtained during cross validation for
EBBag using all features.

Figure 13: Average ROC curves and AUC obtained during cross validation for
EBBag using the pruned features.

Figure 14: Average ROC curves and AUC obtained during cross validation using
EBBag for each tuned model using the pruned features.
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CHAPTER 5
Results
In this chapter, we discuss the results from testing our trained models on
unseen data, and the limitations of our research.
5.1

Testing Results
This section describes the final results obtained in the testing phase using both

the EBBag and SMOTE class imbalance methods. The results here were obtained
using the test set described in Section 4.1. This test set consists of 20% of the
original universal withdrawal and universal non-withdrawal datasets. The data in
the test set has never been seen by any of the machine learning models during their
development. The results from evaluating the trained machine learning models on
the test set demonstrates how well our models generalize to unseen data.
To first develop a baseline understanding for how our models perform during
testing, we performed testing with our class imbalanced testing dataset using all 66
features and untuned models. The ROC Curves and AUC for each algorithm for
this baseline test are shown in Figure 15. What is shown in this figure is that all
untuned algorithms perform exceptionally well using no class imbalance technique,
and all 66 features. The Random Forest performs especially well (AUC = 0.9784),
and again has fairly close to near perfect classification. All algorithms using no
class imbalance technique, untuned models, and all 66 features performed similarly
if not better on the test set compared to cross validation in the training phase.
Now that we have provided a baseline for performance We have summarized
the results of the testing phase using each class imbalance technique (SMOTE,
EBBag) by showing each models receiver operating characteristic (ROC) curve,
and ROC area under the curve (AUC).
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Figure 15: ROC curves and AUC obtained during testing phase using class imbalanced data with untuned models and the pruned features.
5.1.1

SMOTE Results

Figure 16 shows the ROC curve and ROC AUC obtained for each untuned
model during testing using the SMOTE class imbalance technique. Figure 17 shows
the ROC curve and ROC AUC obtained for each tuned model during testing using
the SMOTE class imbalance technique. These results show that both the tuned
and untuned models using SMOTE obtained similar results on the test set. The
tuned Random Forest (AUC = 0.9880) and Decision Tree (AUC = 0.9630) models
were the best two performing algorithms.
The testing results using SMOTE show for all of the algorithms except the Decision Tree, that the tuned models only performed slightly better than the untuned
models. There is a noticeable improvement in classification accuracy during testing for the Decision Tree when using the tuned model (AUC = 0.9630) versus the
untuned model (AUC = 0.9481). These same Decision Tree models during model
development in the training procedure obtained an average ROC AUC of 0.9235,
which was worse than the results obtained during testing. The Random Forest
algorithm using SMOTE performed nearly equal during testing using the tuned
model (ROC AUC = 0.9880) versus the untuned model (ROC AUC = 0.9873).
These same models using SMOTE achieved almost the exact same results during
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Figure 16: ROC curves and AUC obtained during testing phase using SMOTE
with untuned models and the pruned features.

Figure 17: ROC curves and AUC obtained during testing phase using SMOTE
with tuned models and the pruned features.
model development in the training procedure (both with an average ROC AUC of
0.9839). The Logistic Regression algorithm using SMOTE had very similar results
during testing between the tuned model (ROC AUC = 0.8562) and the untuned
model (ROC AUC = 0.8512). Again, these same Logistic Regression models using
SMOTE performed only slightly better during model development in the training
procedure (the tuned model obtained an average ROC AUC of 0.8658 versus the
untuned model with an average ROC AUC of 0.8651). The Support Vector Machine (SVM) algorithm using SMOTE had the same results during testing using
the tuned and untuned models (ROC AUC = 0.7580). These results obtained
during testing with the SVM models are worse than the results obtained during
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model development in the training procedure (both the tuned and untuned SVM
models during training obtained an average ROC AUC of 0.8111).
5.1.2

EBBag Results

Figure 18 shows the ROC curve and ROC AUC obtained for each untuned
model during testing using the EBBag class imbalance technique. Figure 19 shows
the ROC curve and ROC AUC obtained for each tuned model during testing using
the EBBag class imbalance technique. These results show that both the tuned and
untuned models using EBBag obtained similar results on the test set. The untuned
Random Forest (ROC AUC = 0.9997), and the tuned Decision Tree (ROC AUC
= 0.9731) models were the best two performing algorithms.
The testing results using EBBag once again show for all of the algorithms except the Decision Tree, that the tuned models only performed slightly better than
the untuned models. For the Decision Tree using EBBag, the ROC AUC using
the untuned model was 0.9451 versus a ROC AUC of 0.9731 for the tuned model.
These same Decision Tree models during model development in the training procedure performed worse than during testing. During model development, the tuned
Decision Tree model obtained an average ROC AUC of 0.9321 and the untuned
model obtained an average ROC AUC of 0.9273. The Random Forest algorithm
using EBBag again achieved almost the exact same results during testing using
the tuned model (ROC AUC = 0.9944) versus the untuned model (ROC AUC =
0.9997). These same models using EBBag achieved similar results during training (both untuned and tuned Random Forest models obtained an average ROC
AUC of 0.9877). The Logistic Regression algorithm using EBBag also had very
similar results during testing between the tuned (ROC AUC = 0.8438) and the untuned model (ROC AUC = 0.8457). These same Logistic Regression models using
EBBag performed only slightly better during the training procedure (the tuned
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Figure 18: ROC curves and AUC obtained during testing phase using EBBag with
untuned models and the pruned features.

Figure 19: ROC curves and AUC obtained during testing phase using EBBag with
tuned models and the pruned features.
model obtained an average ROC AUC of 0.8594 versus the untuned model with
an average ROC AUC of 0.8580). The Support Vector Machine (SVM) algorithm
using EBBag had the same results during testing using the tuned and untuned
models (ROC AUC = 0.8519). These results obtained during testing with the
SVM models are in this case slightly better than those obtained during model
development in the training procedure (both the tuned and untuned SVM models
during training obtained an average ROC AUC of 0.8438).
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5.1.3

Comparison Between Using Imbalanced Data And Using
SMOTE or EBBag

The baseline testing results obtained with untuned models using imbalanced
data and all 66 features (see Figure 15) can now be compared to the results obtained using SMOTE (see Figure 16, 17) and EBBag (see Figure 18, 19). When
comparing the untuned models using imbalanced data to the models using SMOTE
and EBBag, we can see that the Decision Tree performs far better using SMOTE
(AUC = 0.9630) or EBBag (AUC = 0.9731) compared to using an untuned Decision Tree with imbalanced data (AUC = 0.8870). The Random Forest model on
the other hand only performed slightly better using SMOTE (AUC = 0.9880) or
EBBag (AUC = 0.9997) compared to using an untuned Random Forest model with
imbalanced data (AUC = 0.9784). It is important to note that the models using
SMOTE or EBBag may or may not be tuned models, and they are using pruned
feature sets found during the training phase. Surprisingly, the untuned Logistic
Regression and Support Vector Machine models using imbalanced data performed
similarly, if not better than those same models using SMOTE or EBBag. In general, the untuned models using imbalanced data performed well on the test set and
were very capable of accurately identifying opioid withdrawal.
5.1.4

Final Takeaways

The results obtained during the training procedure using both SMOTE and
EBBag found that there was little improvement in classification accuracy for all
four tuned models versus untuned models. This is generally true for the result
found during the testing procedure, however, it was found during testing that the
tuned Decision Tree model using SMOTE and EBBag had a noticeable improvement in classification accuracy compared to the untuned model.
Further, we find that our testing results show that for some algorithms (Ran-
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dom Forest, Decision Tree) there is some benefit to using SMOTE and EBBag
(along with our training methodology) compared to training untuned models with
imbalanced data and all 66 features. However, without using SMOTE or EBBag
the baseline results using untuned models with imbalanced data and all 66 features
still perform well. This shows that for this dataset these class imbalance techniques
(or others) are not necessary to develop a model that can identify withdrawal with
near perfect accuracy. We know this because the untuned Random Forest trained
with imbalanced data and all 66 features obtained a testing ROC AUC of 0.9784.
Although the results obtained in testing are very good, they need to be understood in context. Given that this is a new area of research and the general dearth
of datasets for this work, we have had to work with a small dataset. We have
thus demonstrated through our training and testing process that using machine
learning classifiers for detecting opioid withdrawal (in near real-time; 1 minute)
from wearable biosensor data is viable. Given that this the first work in this area,
we believe this is an important contribution. That being said, we do not claim to
have produced generalizable classifiers for this particular task.
To further question and verify our testing results, we decided to perform leaveone-out cross validation. This testing methodology and the results obtained are
discussed in detail in the next section.
5.2

Verification Of Testing Results
In this section, we describe how we attempted to verify our testing results

shown in the previous section.
5.2.1

Leave-One-Out Cross Validation

In order to verify our testing results, we decided to perform leave-one-out
cross validation. Performing leave-one-out cross validation helps us verify that our
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models are not just simply learning what withdrawal looks like for each of the
individual six subjects with withdrawal data in the training set. All of the models
used in this process were untuned, and all 66 features were used. To perform
leave-one-out cross validation, we performed 6-fold cross validation where for each
fold we leave out the entire set of withdrawal data for a particular subject to be
used in the test set. Then we randomly sample 10% of the non-withdrawal data
to be in the test set as well. For each fold, we train our four different algorithms
using all of the withdrawal data for 5 patients, as well as the remaining 90% of the
non-withdrawal data. We then test those models using the test set that consists of
all of the withdrawal data for one patients, as well as the randomly sampled 10%
of the non-withdrawal data. We then average the results for all six folds to obtain
an average accuracy for each model.
Leave-one-out cross validation was performed using the imbalanced data,
SMOTE, and EBBag. Again, all of the models trained were untuned, and the
training and testing data consisted of all 66 features. In Figure 20, we show the
average ROC curves and AUC for each algorithm using the imbalanced dataset.
In Figure 21, we show the average ROC curves and AUC for each algorithm using SMOTE. In Figure 22, we show the average ROC curves and AUC for each
algorithm using EBBag.
What the leave-one-out cross validation results show is that on average the
Random Forest algorithm still performs well, especially using SMOTE (avg. AUC
= 0.8338). The Logistic Regression and Support Vector Machine algorithms on the
other hand struggle to classify nearly as well as they did during testing, with their
average ROC AUC falling between 0.6411 and 0.7134. The Decision Tree algorithm
struggles when using imbalanced data (AUC = 0.6771), but performs much better
using SMOTE (AUC = 0.7430) and EBBag (AUC = 0.7908). Overall, these results
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are worse than those obtained using the 20% test set, but they demonstrate that
the models still have some predictive power for identifying withdrawal in unseen
subject data.
5.3

Limitations
The results of this study show that there is promise in using wearable biosen-

sors to identify opioid withdrawal. However, there are two major limitations in
our work that need to be addressed in future work.
The first major limitation of this study is the small amount of opioid withdrawal state data that we had access to. This is in large part due to that fact that
collecting this type of data is subject to if and when an OUD patient experiences
opioid withdrawal symptoms.
For the data that was able to be collected from OUD patients experiencing
withdrawal in this study, there were issues with noise in the data that may have
rendered portions of it to be unusable in this analysis.
The second limitation of this study is that we only collected data that represents naloxone induced opioid withdrawal. The symptoms of a precipitated withdrawal onset by naloxone will be shorter, and possibly more extreme than the
spontaneous withdrawal that occurs when opioid use is reduced or stopped altogether [1]. Therefore, these results may not generalize well to detecting spontaneous opioid withdrawal.
List of References
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Figure 20: Average ROC curves and AUC obtained during leave-one-out cross
validation using imbalanced data.

Figure 21: Average ROC curves and AUC obtained during leave-one-out cross
validation using SMOTE.

Figure 22: Average ROC curves and AUC obtained during leave-one-out cross
validation using EBBag.
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CHAPTER 6
Conclusion And Future Work
In this chapter, we draw conclusions from the results shown in Chapter 5, and
discuss how we plan to continue our work.
6.1

Conclusions
In this study, we proposed a method for developing a set of machine learning

models to identify opioid withdrawal using data collected from a wearable biosensor. We found through our training and testing procedures that the Random Forest
model produced the best results. The test accuracy using this model was nearly
perfect (ROC AUC=0.9997). This model only used the pruned feature set developed during the model training process, and did not undergo any model tuning
with a grid search.
Further, we verified our testing results by performing leave-one-out cross validation, where for each fold we left out the entire set of withdrawal data for a
particular subject to be used in the test set. Then for each fold we trained our
four different algorithms using all of the withdrawal data for the remaining 5 subjects, and then tested these models with the holdout set that contained all of
the withdrawal data for one particular subject. Averaging across all 6 folds, the
top performing model achieved an average ROC AUC of 0.8338 (untuned model,
using SMOTE and all 66 features). This supplementary test helped verify that
during the training and testing phases our models are not just simply memorizing
what withdrawal looks like for the six different subjects with withdrawal data in
the training set. Instead, there are clear patterns in the withdrawal data that our
models are able to pick up on in order to accuracy identify opioid withdrawal using
data collected with a wearable biosensors.
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The results during training and testing did reveal that class imbalance techniques such as SMOTE or EBBag are not necessary to develop a model for this
dataset that can identify withdrawal with near perfect accuracy. During testing,
the untuned Logistic Regression and Support Vector Machine models using imbalanced data and all 66 features performed equal or better than those same models
using SMOTE or EBBag. On the other hand, our testing results showed that the
Decision Tree and Random Forest models using SMOTE and EBBag outperformed
the untuned Random Forest and Decision Tree models using imbalanced data and
all 66 features. Again, it is important to note that the models using SMOTE or
EBBag may or may not be tuned models, and they are using pruned feature sets
found during the training phase. Our methodology has shown that performing
feature pruning helps improve model performance, and this provides evidence for
why the models using SMOTE or EBBag may perform better than untuned models
using imbalanced data and all 66 features.
Our testing results also showed that the grid search process performed during
model development for our four algorithms did not prove to be very beneficial.
This will be discussed further in Section 6.2.
Overall, the results obtained in this study need to be understood in context.
This research has only demonstrated the viability of the proposed methodology,
and it has not produced a perfect classifier for this particular task.
The most important outcome from our analysis is that identifying opioid withdrawal using data collected from wearable biosensors can be successfully done.
This provides a justification for further research, and to explore the use of wearable biosensors to monitor OUD patients during their detoxification process. In the
future, health care providers will be able to equip an OUD patient undergoing the
detoxification process with a wearable biosensor. During the detoxification pro-
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cess, this wearable biosensor will collect and transmit an OUD patient’s biometric
data to a cloud-based server, where an opioid withdrawal identification algorithm
(similar to ours) will process and classify their data as being in withdrawal or
non-withdrawal. If a patient’s biometric data is found to be in the withdrawal
state, their health care provider will be alerted, and they can then implement a
personalized treatment plan for mitigating the opioid withdrawal symptoms. Implementing personalized treatments will help stop or lessen their patient’s withdrawal
symptoms, and as a result will help prevent the relapse of opioid use and overdose.
6.2

Future Work
In the future, we plan to improve upon this work in three different ways.

(1) We plan to collect additional data from OUD patients experiencing naloxone
induced withdrawal symptoms. The increase in data will help to address the issue of model generalizability. (2) Similarly, data will also be collected from OUD
patients experiencing spontaneous withdrawal symptoms onset from discontinuing
or limiting their opioid use. This data would allow us to understand how well a
model built to detect naloxone induced withdrawal symptoms can generalize to
spontaneous withdrawal symptoms. It would also enable us to study building a
model to identify spontaneous withdrawal symptoms, or both precipitated and
spontaneous withdrawal symptoms. (3) We will further investigate how performing hyper-parameter tuning can improve our models performance. Our current
approach of using a grid search was not significant enough to add any sizable improvement to model performance. In future work we may instead decide to try
performing a randomized grid search prior to choosing a set of parameters for a
grid search, or try a different hyper-parameter tuning approach altogether.
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